>UBA1008|DBAO01000148.1_17 # 23762 # 24631 # -1 # ID=72_17;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.385|DBAO01000148.1_17 |23762|24631|-|Loose|500|42.0|NDM-13|24.76|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|107.04|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTLYTIETGNFKLDGGAMFGVVPKTIWQKTNPADEKNLIDIAARSLLIEDGDKLILIDTGLGNKQSDKFFGYYYRWGNDSIDSSLAKHGFHRDDITDVFMTHLHFDHCGGSIQWNKDRSGFEPAFKNAKFWTNKDHWKWAIEPNAREKASFLKENLLPMQESGQLNFIDRGTDAFLKNSVLGFDVLFVDGHTDKQMLPHIRYKGKTLVFVADLIPTVGHIPLPYVIGYDTRPLLTLKEKDVFLKEALKNEYFLFFEHDAHNEICTLRETEKGARLDNTFTFNELFNTTA
>UBA1015|DBAH01000016.1_3 # 2557 # 3420 # 1 # ID=202_3;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=11bp;gc_cont=0.380|DBAH01000016.1_3 |2557|3420|+|Loose|500|39.3|NDM-5|25.0|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MQLYPIEAGNFKLDGGAMFGVVPKSIWQKTNPADSNNMIDIGARSLLIEDGNRLILIDTGLGDKQSEKFFSYYYQWGDDSLDKSLQKNGFHRDDITDVFTTHLHFDHCGGCVQWNKDRTGYETVFKNAKYWSNKDHWQWATTPNAREKASFLKENILPIEESGQLHFVDRNNKEHFTNIPELGFGVLFVDGHTDKQMIPHLEYKGKKLVFMADLLPTAGHIPLPYVMGYDTRPLLTLPEKKSFLDKAADEEIYLFMQHDAHNEVITVKHTEKGVRHDQTYTFNELFN
>UBA1115|DCBE01000034.1_15 # 13735 # 14598 # -1 # ID=45_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.442|DCBE01000034.1_15 |13735|14598|-|Loose|500|38.5|NDM-5|24.76|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MKLHIIETGNFKLDGGAMFGVVPKTLWNKTNPADSQNRIDLAARSLLIEDGDRLILIDTGMGDKQDDRFFRHFGLYGEKSLNRSIEKAGFSRNDITDVFLTHLHFDHCGGAVRWNEGKTAYELSFPNARYWSNEQHWAWAINPNGREKASFLSENLMPIQDSGQLHFIERPVSNFVSDCGLGFGALFVDGHTEKQMIPHLTYRGKTIVFMADLLPTVGHLPLPYIMGYDVRPLDTLQEKKLFLNRAAKENFLLFMQHDANHPLVTVQQTEKGVRLHETLAAETLNIL
>UBA1162|DBZK01000030.1_23 # 27247 # 28179 # 1 # ID=30_23;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.496|DBZK01000030.1_23 |27247|28179|+|Loose|500|45.8|NDM-13|31.25|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|114.81|gnl|BL_ORD_ID|430|hsp_num:0|464||
MQLPENPLQAVNSYLLKGDGRFLIIDTGMNMEVCAKALNAGLQQLNVDLKKTDFFVTHLHHDHMGLVSALATEGAKVYFNQPEIPIMRQFTSNTRWATLLNFNVANGFSEKELINSMPNLSYLYGTKQLPFIALHDGDGFEIGEYCFTCIETPGHSPGHICLYEKDKKLLVSGDHILFDITPNITWYPEMPNSLERYLHSLDKVYPLDVELVLPGHRKHQNNHRARIREIQEHHNIRLKETAAALESGEKTAYDVAANISWDITYTSWEDFPVTQKYFAVGETIAHLQYLADAKRIRKYAADGKTLYSLA
>UBA1383|DBQX01000015.1_33 # 28519 # 29250 # 1 # ID=105_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.736|DBQX01000015.1_33 |28519|29250|+|Loose|500|46.6|NDM-10|26.32|3002360|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|90.00|gnl|BL_ORD_ID|61|hsp_num:0|70||
MEPREFADGVWVFTSRAMCTTTTVVAGRRTAAGRSVLLVDPAWEPDELVGIADWLDRNGMVVGAGWATHAHYDHVLWHPRFGAAPRWATTAAATYASGHCASLVAGLGPDWPRDLAPLVGAVTGWDGDEVPWDGPLVRVVRHSAHCPGHSALWVERAEVLIAGDMLSDIEIPLPDSEGISGYLRGLRLLEPWVRRARVLVPGHGRVAVRGEADSPESRLALDLAYLSDPARATGDPRLRNAPE
>UBA1493|DCRL01000020.1_99 # 110052 # 110912 # 1 # ID=46_99;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.365|DCRL01000020.1_99 |110052|110912|+|Loose|500|44.7|NDM-3|25.71|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MKIYPIETGNFKLDGGAMFGVVPKTIWQRTNPADENNLIDIAARSLLIEDGDRLVLIDTGMGNKQSDQFFGYYYRWGDFNIDSSLNKYGFHRDDITDVFLTHLHFDHVGGAIQWNKDRTGYEPAFKNAKFWTNEKHWKWATEPNPREKASFLKENLYPMKESGQLTFIDPTDNSFLKNSQLGFDIRFVDGHTEKQMLPQFTYQDKTIAYMADLIPTVGHIPLPYVIGYDTRPLVTMTEKEIFLNEAVENNYYLFFEHDAHNQLCTLKHTERGVRLDQVYTFNELFN
>UBA1523|DCQH01000053.1_5 # 4984 # 5853 # -1 # ID=11_5;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.385|DCQH01000053.1_5 |4984|5853|-|Loose|500|42.0|NDM-13|24.76|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|107.04|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTLYTIETGNFKLDGGAMFGVVPKTIWQKTNPADEKNLIDIAARSLLIEDGDKLILIDTGLGNKQSDKFFGYYYRWGNDSIDSSLAKHGFHRDDITDVFMTHLHFDHCGGSIQWNKDRSGFEPAFKNAKFWTNKDHWKWAIEPNAREKASFLKENLLPMQESGQLNFIDRGTDAFLKNSVLGFDVLFVDGHTDKQMLPHIRYKGKTLVFVADLIPTVGHIPLPYVIGYDTRPLLTLKEKDVFLKEALKNEYFLFFEHDAHNEICTLRETEKGARLDNTFTFNELFNTTA
>UBA1552|DCPE01000030.1_10 # 12287 # 13150 # 1 # ID=95_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.396|DCPE01000030.1_10 |12287|13150|+|Loose|500|39.7|NDM-13|25.71|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|430|hsp_num:0|464||
MQIYPIETGNFKLDGGAMFGVVPKSIWQKTNPADSNNLIDMALRCLLIEDGNRLILIDTGTGNKQPDKFFSYYFMFGDFTLDRSLAKYGFHRDDLTDVFLTHLHFDHCGGSIQWNKAHTDYEPAFKNAKFWSNKAHWKWATEPNPREKASFLKENIHPMQTSGQLNFLDLPTSGNFSKNTPLGFDVFFADGHTDKQMIPHIKYRDKTIVYVADLLPTVGHIPLPYVMGYDTRPLLTMDEKATFLNTAADNNYYLFLEHDAANQLCTVQHTDKGVRLKDTFTFNEIFN
>UBA1593|DCNP01000017.1_1 # 454 # 1239 # -1 # ID=49_1;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.561|DCNP01000017.1_1 |454|1239|-|Loose|500|40.4|NDM-5|36.17|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|96.67|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MCLILIAYRYQPGYPLLIAANRDEFYNRPTEPLAQWQDTPHIIAGRDIQGGGTWLGITTTGRFAALTNYRDPSRLTPNAPSRGQLVSDYLRCTEPARQYLDRVVERANLYNGFNLLLGDSEGLFYYANYEGRPRELKPGLYGLSNHFLDTPWPKVERARTALRQILDQHAEPIPEDLLGLLRDQEPAPDHQLPDTGIPLEWERWLSPIFITAPGYGTRASTALCVQDSGRVRLVEITWPEHSQRQFQIEWPPLKLGIGHSP
>UBA1658|DCLC01000002.1_774 # 986699 # 987568 # 1 # ID=11_774;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.386|DCLC01000002.1_774 |986699|987568|+|Loose|500|42.0|NDM-13|24.76|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|107.04|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTLYTIETGNFKLDGGAMFGVVPKTIWQKTNPADEKNLIDIAARSLLIEDGDKLILIDTGLGNKQSDKFFGYYYRWGNDSIDSSLAKHGFHRDDITDVFMTHLHFDHCGGSIQWNKDRSGFEPAFKNAKFWTNKDHWKWAIEPNAREKASFLKENLLPMQESGQLNFIDRGTDAFLKNSVLGFDVLFVDGHTDKQMLPHIRYKGKTLVFVADLIPTVGHIPLPYVIGYDTRPLLTLKEKDVFLKEALKNEYFLFFEHDAHNEICTLRETEKGARLDNTFTFNELFNTTA
>UBA1682|DCKE01000001.1_25 # 37994 # 38851 # 1 # ID=20_25;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=11bp;gc_cont=0.423|DCKE01000001.1_25 |37994|38851|+|Loose|500|38.5|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.56|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYAIESGNFKLDGGAMFGVVPKTIWNRTNPADSNNLIDIAARLLLIEDGNRLILIDTGMGNKQSEKFFGYYSLWGDHSIDKSLAQHGFHRDDITDVFLTHLHFDHSGGAINWNADRTGYVTAFKNAKYWSNDKHWDWAVHPNDREKASFLKENILPIQESGQLSFITRPENDLLYKSELDFGIFFADGHTEKQMIPLIDYQGKKIAYVADLLPTAGHIPLPYVMGYDTRPLLTLKEKEKFLKTAADENYYLLLGHDAHNQIITVQNTDKGVRLNEVFRCEDIF
>UBA1759|DCHF01000026.1_67 # 71361 # 72176 # 1 # ID=38_67;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.538|DCHF01000026.1_67 |71361|72176|+|Loose|500|42.7|NDM-11|25.55|3002361|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|100.37|gnl|BL_ORD_ID|2427|hsp_num:0|3254||
MQNNIVHTGNLSTVYTAARDVFVREGNLPVRDQCNTGIIVLDSCVAVIDLSNQDPDEEIFLEAEKVTGFPVKYLLLTHAHGDHMIGMKTLHRSDFALIARDTAIGELKRNDVPLPEKVISVTGDTMLELDGREFSLFIPKEHGHSPWDMLIGLPDCGLLFGGDLIAKRSDMYLHSACIDGWIVDIHTLIEELKDSVYTDIVQGHGDMIPVSELADVENYLEDLRAAAGFEQENMRETEDFRNLYRKLIDRSVRKDVDRQIETILHNNGVSL
>UBA1979|DDDN01000108.1_2 # 1139 # 2350 # 1 # ID=58_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.524|DDDN01000108.1_2 |1139|2350|+|Loose|500|40.0|NDM-13|32.04|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|149.26|gnl|BL_ORD_ID|430|hsp_num:0|464||
MCISPTHPTALKVQLGRNLRQRHGCYINAANATRIHADDKIYSTTMNVQNTSATQPISYPIEAHPDVGEIIEIAPGVQWLSMPIPGSLAFINVYLLRDHNGWWIVDTGVSNDQTTQLWQRIFTERFTDEPVVGLICTHMHPDHTGQARMITEHFQCPLYMTRGEYYQARAFANNAGESHSGWIGQRFYHRAGMPADFLEEIGKMWSKRSNEGMSMPTLPGGYERLVEDQVLTIGGNDWRVVIGSGHSPEHACLYCADLKLLIAGDQILPIITSNVSVHPSEPNANPLKDWMDSHERLLTVIPDDTFVLPGHNLPFYGVQTRLRDLIDHHDERMQAIADVCVEPQVAKDLLPVLFNRALDPGQTMMALGEAIAHVHLLIHHNRLERVLGEDGIDRFHTIDPNHP
>UBA2247|DDXZ01000016.1_3 # 1398 # 2459 # 1 # ID=67_3;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.429|DDXZ01000016.1_3 |1398|2459|+|Loose|500|40.0|NDM-13|20.19|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|130.74|gnl|BL_ORD_ID|430|hsp_num:0|464||
MLAEEHRIGLNFYYLLDVAKLVITGERMIEQILPELYRMEIPLPGSPLKAVNSYLIKGEGRFLIIDTGMKREECQEAMFAALKELNVDLRKTDFFITHLHADHLGLVALMATNNAKVYFSRMEAQIINRNSGEEDRLEDTSRYFISHGYPEDVLKLSVASHPGRRYGLRQHIDFSIVKEGDKIDVGDYSFQCIETPGHSPCHMCLYEPDKKLLLSGDHILADITPNISYWGELENPLKKYLTNLDKVYPLDVSLTLPGHRSLIKDHRKRIGELKAHHQDRVKEVLFALESGAKTAYQVAPYIKWDIKASSWEQFPAAQKWFAFGETLAHLIYMEKEGMVQEKKEGNRILFHLA
>UBA2343|DDUH01000065.1_2 # 714 # 1565 # 1 # ID=42_2;partial=00;start_type=ATG;rbs_motif=AAGAA;rbs_spacer=5bp;gc_cont=0.432|DDUH01000065.1_2 |714|1565|+|Loose|500|39.7|NDM-13|25.71|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|104.81|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYVLETGNFKLDGGAMFGVVPKTIWQRTNPADENNMCTWAMRCLLIEDGKRLMLVDTGIGNKQDEKFFSHYFLHGDATLDSSLQKLGFSRDQITDVFLTHLHFDHCGGAIEFDKSKDAFRPAFANATYWSNDRHWGWATQPNPREKASFLKENILPIKESGQLKMIERKEDLTAEVFPGIDVLFVDGHTDSMMIPHIRYKGKTIVYMADLLPSTGHIPLPYVMGYDTRPLLTISEKERFLKRAADEEFVLLLEHDSVNECCTLQHTEKGVRLKETFRFSEI
>UBA2382|DDSU01000001.1_53 # 64353 # 65204 # 1 # ID=23_53;partial=00;start_type=ATG;rbs_motif=AAGAA;rbs_spacer=5bp;gc_cont=0.432|DDSU01000001.1_53 |64353|65204|+|Loose|500|39.7|NDM-13|25.71|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|104.81|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYVLETGNFKLDGGAMFGVVPKTIWQRTNPADENNMCTWAMRCLLIEDGKRLMLVDTGIGNKQDEKFFSHYFLHGDATLDSSLQKLGFSRDQITDVFLTHLHFDHCGGAIEFDKSKDAFRPAFANATYWSNDRHWGWATQPNPREKASFLKENILPIKESGQLKMIERKEDLTAEVFPGIDVLFVDGHTDSMMIPHIRYKGKTIVYMADLLPSTGHIPLPYVMGYDTRPLLTISEKERFLKRAADEEFVLLLEHDSVNECCTLQHTEKGVRLKETFRFSEI
>UBA2423|DDRF01000119.1_9 # 12678 # 13529 # 1 # ID=18_9;partial=00;start_type=ATG;rbs_motif=AAGAA;rbs_spacer=5bp;gc_cont=0.432|DDRF01000119.1_9 |12678|13529|+|Loose|500|39.7|NDM-13|25.71|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|104.81|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYVLETGNFKLDGGAMFGVVPKTIWQRTNPADENNMCTWAMRCLLIEDGKRLMLVDTGIGNKQDEKFFSHYFLHGDATLDSSLQKLGFSRDQITDVFLTHLHFDHCGGAIEFDKSKDAFRPAFANATYWSNDRHWGWATQPNPREKASFLKENILPIKESGQLKMIERKEDLTAEVFPGIDVLFVDGHTDSMMIPHIRYKGKTIVYMADLLPSTGHIPLPYVMGYDTRPLLTISEKERFLKRAADEEFVLLLEHDSVNECCTLQHTEKGVRLKETFRFSEI
>UBA2693|DELP01000001.1_441 # 491575 # 492438 # -1 # ID=2_441;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=10bp;gc_cont=0.367|DELP01000001.1_441 |491575|492438|-|Loose|500|40.4|NDM-5|24.76|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MTLHPIESGNFKLDGGAMFGVVPKSLWTRTNPADANNMIDMAARCLLIEDGDRLILIDTGMGDKQSEKFFGYYYMWGDHSLDASLAKAGFHRDDITDVFLTHLHFDHCGGCIINNPNGNGYLPAFKNAKFWTNENHWNWAVNPNAREKASFLKENILPMQDSGQLNFIKKTTKDSFQTSSELDFGIFFADGHTEKQMIPRIDYKEKTLVFAADLLPTAGHIPLPYVMGYDTRPLLTLDEKAQFLNEAADHNHYIFLEHDAHNEIITVQHTDKGVRLKDTYTFNQLFK
>UBA2700|DELI01000020.1_111 # 129673 # 130515 # 1 # ID=7_111;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.415|DELI01000020.1_111 |129673|130515|+|Loose|500|42.0|NDM-5|29.17|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|103.70|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MKLYTIDTGFFKLDGGAMFGVVPKSIWQKTNPADSNNLCTWATRLLLIEDGKRLTLVDTALGDKQDAKFFGHYFLHGDDTLDNSLARHGFHRDDITDVILTHLHFDHCGGAIIRQGEKLVPAFKNARFWSNEKHWNWATIEPNPRERASFLKENILPIQESGQLNFISEDQPHYDSNIKMRYAYGHTEAMMLPQIDYKGKTLLYMADLLPSVGHIPLAYVMSYDVRPLVTMDERKSYWQEIVDNEYILILEHDAEHECCTLQHTEKGIRLKDTFKLSDIA
>UBA2788|DEHY01000027.1_1 # 333 # 1106 # -1 # ID=192_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.632|DEHY01000027.1_1 |333|1106|-|Loose|500|39.3|NDM-5|43.24|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|95.19|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MCLILIAYRRHPRYPLLVAANRDEFHDRPTAPLAFWDDLPQIIAGRDLKEGGTWMGIDRTGRFAAITNYRDPSRASPNAPSRGHLVSNFLRSAEPARVYLDRLAPKARAYNGFNLVLGDAEGLFYYSNCDSGEFRALVPGLYGLSNHLLDTPWPKLERGRRALRQLLDRQPDPTPDELLELLADRTLAPDSDLPRTGVPLEWERWLSPIFIDAPGYGTRSSTALRVDAGGRAWLVETTWADGSRREFQLDGPSENPA
>UBA2798|DEHO01000025.1_55 # 49633 # 50484 # -1 # ID=77_55;partial=00;start_type=ATG;rbs_motif=AAGAA;rbs_spacer=5bp;gc_cont=0.433|DEHO01000025.1_55 |49633|50484|-|Loose|500|39.7|NDM-13|25.71|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|104.81|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYVLETGNFKLDGGAMFGVVPKTIWQRTNPADENNMCTWAMRCLLIEDGKRLMLVDTGIGNKQDEKFFSHYFLHGDATLDSSLQKLGFSRDQITDVFLTHLHFDHCGGAIEFDKSKDAFRPAFANATYWSNDRHWGWATQPNPREKASFLKENILPIKESGQLKMIERKEDLTAEVFPGIDVLFVDGHTDSMMIPHIRYKGKTIVYMADLLPSTGHIPLPYVMGYDTRPLLTISEKERFLKRAADEEFVLLLEHDSVNECCTLQHTEKGVRLKETFRFSEI
>UBA2955|DEBN01000010.1_11 # 10511 # 11722 # -1 # ID=80_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.525|DEBN01000010.1_11 |10511|11722|-|Loose|500|40.0|NDM-13|32.04|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|149.26|gnl|BL_ORD_ID|430|hsp_num:0|464||
MCISPTHPTALKVQLGRNLRQRHGCYINAANATRIHADDKIYSTTMNVQNTSATQPISYPIEAHPDVGEIIEIAPGVQWLSMPIPGSLAFINVYLLRDHNGWWIVDTGVSNDQTTQLWQRIFTERFTDEPVVGLICTHMHPDHTGQARMITEHFQCPLYMTRGEYYQARAFANNAGESHSGWIGQRFYHRAGMPADFLEEIGKMWSKRSNEGMSMPTLPGGYERLVEDQVLTIGGNDWRVVIGSGHSPEHACLYCADLKLLIAGDQILPIITSNVSVHPSEPNANPLKDWMDSHERLLTVIPDDTFVLPGHNLPFYGVQTRLRDLIDHHDERMQAIADVCVEPQVAKDLLPVLFNRALDPGQTMMALGEAIAHVHLLIHHNRLERVLGEDGIDRFHTIDPNHP
>UBA2997|DDZX01000005.1_24 # 29561 # 30406 # 1 # ID=15_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.472|DDZX01000005.1_24 |29561|30406|+|Loose|500|38.5|NDM-5|25.66|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|104.07|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MRIGNFDVTTLITSRFGLDGGSMFGVIPKSIWDKNAAVDSDNRISLVTRSLLIRGDGRIILVDTGSGDKWDGKMKNILAIDPTETNITDTLAQHAVLPDEVTDVICTHLHFDHSGGNTRIEGDQTIPTFPNATYHLQRDNWEWASSPTEKDRGSYRSENWEAITENGMFNLLEAKEPIFDNIKLHLTHGHTPGQMHPILTEGEKTLFFAGDLFPTRLHFRLPCIMAFDNEPLKTLMEKKEVLRRASDEGWIIILAHDPDCEAVKVYAQGDRFQIEKVFNLD
>UBA3135|DEZJ01000050.1_55 # 48639 # 49448 # -1 # ID=8_55;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=15bp;gc_cont=0.501|DEZJ01000050.1_55 |48639|49448|-|Loose|500|38.1|NDM-5|24.73|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|99.63|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MFGVVPKGLWERTNPADERNLCTWAMRSLLIENGDRLILVDTGIGDKQSEKFFSHYFLHGDHSLDASLAAHGFNRNDITDVFLTHLHFDHVGGAVQWNADRTGYEPTFKNATYWTNERHWNWATKPNARERASFLSENILPLQESGQLKFIDAPESEHRVPTPLGFDVFVVNGHTDAQMCPILPYKGKTVVFMADLMPSTGHIPLPYVMGYDTRPLITLDERKRIFTEAAEKGYHLFLEHDAYNEVCTLQMTEKGPRLLENGRLDHFVG
>UBA3143|DEZB01000011.1_27 # 25260 # 27098 # -1 # ID=27_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.431|DEZB01000011.1_27 |25260|27098|-|Loose|500|39.7|NDM-10|32.31|3002360|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|226.67|gnl|BL_ORD_ID|61|hsp_num:0|70||
MIDYDTLKLTDWLPTTKKEMQLRGWDYVDVIFFTGDAYIDHPSFGAAVIGRLLERDGLRIAIVPQPNWRDDLRDFKKLGKPRYFFSVSAGAMDSMINHYTANKRLRSNDAYTPDGRADMRPDRTTIVYSNILKELYPDVPVVLGGIEASLRRVTHYDYWDDKLHKSILCDSKADLLIYGMGEKPLLRLVSELRQGRKIEQLHDIPQTAFLTKKEQVPNNPFKEEERLFSHEECLKDKLKQAKNFRIVEEQSNRMHAARILQDVDSETLVVNPPYLPMTEPEIDDSFDLPYTRLPHPKYKNKTIPAYEMIKFSVNLHRGCFGGCAFCTISAHQGKFIASRSKESILKEVRNVVKMPDFKGYISDLGGPSANMYKMQGKKIAMCEKCKRPSCIHPAVCPNLDTDHTALIDIYKAVDAIKGVKKSFVGSGVRYDMLLHKSKDAITNKAAKDYTEELILNHVSGRLKVAPEHTSDETLYMMRKPSFKDFHIFKNTFERLNKKHGMKQQLIPYFISSHPGCTEADMAELAAITKDLDFKLEQVQDFTPSPMTLATEIYYTGYHPYTLKKVYTAKTTNDKKGQRQFFFWYERAAKKPIIDALKKMNRHDLIKKLYPNG
>UBA3151|DEYT01000009.1_12 # 9949 # 10599 # 1 # ID=64_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.462|DEYT01000009.1_12 |9949|10599|+|Loose|500|48.9|NDM-17|24.24|3004093|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|80.00|gnl|BL_ORD_ID|2275|hsp_num:0|2756||
MNPLKIKGMELGPIATNAFLLWRDGMTQAVLVDAPPNCAEEVNNVLAEENLTLSEIWLTHGHWDHMAGADELNGEDIRIIGHINDRIMFEQPSIMANFAIPGINMDPIKVTHWVKEGEVLDFFGSPVEVRHCPGHCPGNVVFWFKNDSCCFVGDVIFRESVGRYDLPGGDFEKLEVSIQEKIFSLPPETKLLVGHGPPTTVSHEMQSNPFVRPKTL
>UBA3344|DERI01000028.1_115 # 118325 # 119185 # 1 # ID=23_115;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.365|DERI01000028.1_115 |118325|119185|+|Loose|500|44.7|NDM-3|25.71|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MKIYPIETGNFKLDGGAMFGVVPKTIWQRTNPADENNLIDIAARSLLIEDGDRLVLIDTGMGNKQSDQFFGYYYRWGDFNIDSSLNKYGFHRDDITDVFLTHLHFDHVGGAIQWNKDRTGYEPAFKNAKFWTNEKHWKWATEPNPREKASFLKENLYPMKESGQLTFIDPTDNSFLKNSQLGFDIRFVDGHTEKQMLPQFTYQDKTIAYMADLIPTVGHIPLPYVIGYDTRPLVTMTEKEIFLNEAVENNYYLFFEHDAHNQLCTLKHTERGVRLDQVYTFNELFN
>UBA3396|DEPI01000341.1_10 # 13526 # 14389 # 1 # ID=369_10;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=11bp;gc_cont=0.380|DEPI01000341.1_10 |13526|14389|+|Loose|500|39.3|NDM-5|25.0|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MQLYPIEAGNFKLDGGAMFGVVPKSIWQKTNPADSNNMIDIGARSLLIEDGNRLILIDTGLGDKQSEKFFSYYYQWGDDSLDKSLQKNGFHRDDITDVFTTHLHFDHCGGCVQWNKDRTGYETVFKNAKYWSNKDHWQWATTPNAREKASFLKENILPIEESGQLHFVDRNNKEHFTNIPELGFGVLFVDGHTDKQMIPHLEYKGKKLVFMADLLPTAGHIPLPYVMGYDTRPLLTLPEKKSFLDKAADEEIYLFMQHDAHNEVITVKHTEKGVRHDQTYTFNELFN
>UBA3440|DFSJ01000149.1_2 # 255 # 1124 # -1 # ID=15_2;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=3bp;gc_cont=0.515|DFSJ01000149.1_2 |255|1124|-|Loose|500|40.8|NDM-17|26.04|3004093|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|107.04|gnl|BL_ORD_ID|2275|hsp_num:0|2756||
MRLYPIEAGHFKLDGGAMFGVVPQSIWQRTNPPDQNNLIDLATRCLLVEDGNRLTLIDTGMGDKQPESFWKHYHLFGDNNLMGSMKKAGFAPEDITDVLLTHLHFDHCGGAVYRAPSGALEPAFKNARYWVHRTHWDWALAPNAREKASFLSENILPLLESGQLHFLDQTNLSPGSLGAPVFQTPLGFEVFIADGHTEKQLLPLIPMADGICAYGADLIPTLGHIPLAYVMGYDVRPLQTLTEKELFLKWAVKHEWKLFFEHDPSCQGCTLRDTEKGVRSDKLITFNEL
>UBA3477|DFQY01000055.1_18 # 18894 # 19703 # 1 # ID=7_18;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=15bp;gc_cont=0.501|DFQY01000055.1_18 |18894|19703|+|Loose|500|38.1|NDM-5|24.73|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|99.63|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MFGVVPKGLWERTNPADERNLCTWAMRSLLIENGDRLILVDTGIGDKQSEKFFSHYFLHGDHSLDASLAAHGFNRNDITDVFLTHLHFDHVGGAVQWNADRTGYEPTFKNATYWTNERHWNWATKPNARERASFLSENILPLQESGQLKFIDAPESEHRVPTPLGFDVFVVNGHTDAQMCPILPYKGKTVVFMADLMPSTGHIPLPYVMGYDTRPLITLDERKRIFTEAAEKGYHLFLEHDAYNEVCTLQMTEKGPRLLENGRLDHFVG
>UBA3537|DFOQ01000122.1_57 # 61004 # 61906 # 1 # ID=122_57;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=3bp;gc_cont=0.392|DFOQ01000122.1_57 |61004|61906|+|Loose|500|39.3|NDM-10|23.96|3002360|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|111.11|gnl|BL_ORD_ID|61|hsp_num:0|70||
MYFSVFVSTRFIVLIMTLYPLNVGNFKLDGGAMFGVVPKSLWNKTNPADHNNMIEVTARCLLIEEGKRLILIDTGMGNKQSSKFFNYYYRWGEQGVASALAKYGFHKDDVTDVFLTHLHFDHCGGAVERSLKNGRLQLAFKNAKYWTNKQHWFWAKNPNGREKASFLKENIEPIEASGHLNYIKKPEGNILKNSPLGFDILFADGHTEKQMIPIIRYKENTICFMADLLPTVGHVPLPYIMGYDVRPLITLKEKEALLNLAAKHNYYLFLEHDAQHELITVKQTEKGVRLNETYLFNSIL
>UBA3715|DFHU01000051.1_1 # 9 # 824 # -1 # ID=38_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.451|DFHU01000051.1_1 |9|824|-|Loose|500|39.3|NDM-11|24.5|3002361|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|100.37|gnl|BL_ORD_ID|2427|hsp_num:0|3254||
MGWKRKDYRDFSVHVYSAGEDGCLANSYIVETASHLLVIDTQCLLPYAEKVKAMAVRLNKPIARVIITHAHPDHWFGTSVFAGEQIYALPTVRMEMEKDAVTAFQRNKPRLGDKIGDEAVLPNHTLEKGRFVVDGVEIYVHEILNTETSSLAVLEIPAEKILFASDMVYAHTHIYVADNHIEEWIAALKSCQQKSFKDIFPGHGNDFSPQVLQEEMNYLRSAGKVIAEAKSFSEFRQRMLALYPDYAGKLLLELNAMFLVLPLGSHLETDA
>UBA3979|DGCL01000129.1_13 # 17754 # 18617 # -1 # ID=55_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.365|DGCL01000129.1_13 |17754|18617|-|Loose|500|40.4|NDM-5|24.76|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MTLHPIESGNFKLDGGAMFGVVPKSLWTRTNPADANNMIDMAARCLLIEDGDRLILIDTGMGDKQSEKFFGYYYMWGDHSLDASLAKAGFHRDDITDVFLTHLHFDHCGGCIINNPNGNGYLPAFKNAKFWTNENHWNWAVNPNAREKASFLKENILPMQDSGQLNFIKKTTKDSFQTSSELDFGIFFADGHTEKQMIPRIDYKEKTLVFAADLLPTAGHIPLPYVMGYDTRPLLTLDEKAQFLNEAADHNHYIFLEHDAHNEIITVQHTDKGVRLKDTYTFNQLFK
>UBA4086|DFYI01000105.1_8 # 3939 # 5114 # 1 # ID=55_8;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.458|DFYI01000105.1_8 |3939|5114|+|Loose|500|39.3|NDM-13|22.89|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|144.81|gnl|BL_ORD_ID|430|hsp_num:0|464||
MLAEEHRIRLNFYYLLDVAKLVITGERMIEQILPELYRMEIPLPGSPLKAVNSYLIKGEGRFLIIDTGMKREECQEAMFAALKELNVDLRKTDFFITHLHADHLGLVALMATNNAKVYFSRTEAMIINRNSGEEDRLEDTSGHFMSHGYPEDVLKLSVASHPGRRYGLRQHIDFSIVKEGDKIDVGDYSFQCIETPGHSPCHMCLYEPDKKLLLSGDHILADITPNISYWGELENPLKKYLTNLDKIYPLDVSLTLPGHRSLIKDHRKRIGELKAHHQDRVKEVLFALESGAKTAYQVAPYIKWDIKASSWEQFPAAQKWFXXXXXXXXXXXXRRIVMEIKKVGIVGCGFMGSGIARVSAQAGYDVIITDTSETALKKGVASIDYFLSRSV
>UBA4098|DFXW01000041.1_26 # 30030 # 30890 # -1 # ID=41_26;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.397|DFXW01000041.1_26 |30030|30890|-|Loose|500|39.7|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIETGNFKLDGGAMFGVVPKSIWNKTNPADDNNLIDIAARCLLIEDGNRLILIDTGMGNKQSDKFFGYYSLWGSHSLDKSLAKYGFHRDDITDVFMTHLHFDHCGGSIQWNKDRTGYEPAFKNAVFWSNENHWQWATEPNVREKASFLKENIIPMQESGQLRFVQRPEDDYLVKSELGFGILFVDGHTEKQMIPHIQYQDKTIVFCADLLATAGHIPIPYVMGYDTRPLLTMPEKTTFMNSAAENNYYLFLQHDAHNEIIRVEKTERGVRLKDAFSADEILK
>UBA4120|DFXA01000054.1_33 # 50107 # 50967 # -1 # ID=23_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.401|DFXA01000054.1_33 |50107|50967|-|Loose|500|39.7|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIETGNFKLDGGAMFGVVPKTIWNRTNPADENNLIDIAARCLLIEDGNQLILIDTGMGNKQSDKFFGYYSLWGNHSIDKSLAKHGFHRDDITDVFLTHLHFDHCGGSVQWNKDKTGYEVAFKNAKFWTNDSHWEWATKPNVREKASFLSENILPMQESGQLNFIKRPEGDFLPTSELGFGIFFADGHTEKQMLPHIQYQDKTIVFCADLLATAGHIPIPYVMGYDTRPLLTMDEKTKFMNAAAENNYYLFLEHDAHNEIITVEKTEKGVRLKERFSCDDILK
>UBA4167|DFVF01000067.1_13 # 13897 # 14715 # -1 # ID=110_13;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.388|DFVF01000067.1_13 |13897|14715|-|Loose|500|37.7|NDM-13|23.66|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|100.74|gnl|BL_ORD_ID|430|hsp_num:0|464||
MFGVVPKTIWQKTNPADEKNLIDIAARSLLIEDGDKLILIDTGLGNKQSDKFFGYYYRWGNDSIDSSLAKHGFHRDDITDVFMTHLHFDHCGGSIQWNKDRSGFEPAFKNAKFWTNKDHWKWAIEPNAREKASFLKENLLPMQESGQLNFIDRGTDAFLKNSVLGFDVLFVDGHTDKQMLPHIRYKGKTLVFVADLIPTVGHIPLPYVIGYDTRPLLTLKEKDVFLKEALKNEYFLFFEHDAHNEICTLRETEKGARLDNTFTFNELFNTTA
>UBA4197|DFUB01000004.1_17 # 16379 # 17239 # 1 # ID=16_17;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=9bp;gc_cont=0.439|DFUB01000004.1_17 |16379|17239|+|Loose|500|38.9|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIESGNFKLDGGAMFGVVPKTIWNKTNPADENNLIDIAARCLLIEDGNRLILIDTGMGNKQSDKFFGYYSLWGTHSIDKSLAQYGFHRDDITDVFMTHLHFDHCGGSVVWNKDRTGYEVAFKNATYWTNENHWEWATQPNAREKASFLSENILPIQESGQLKFINRPEGDFLEQSELGFGILFADGHTEKQMIPHIQYQDKTLVFCADLLATAGHIPIPYVMGYDTRPLLTLDEKTKFMNNAADKNYFLFLEHDAHNQIITVERTDKGVRLKDVFQCDEILK
>UBA4516|DGMO01000042.1_35 # 55981 # 56841 # -1 # ID=56_35;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.364|DGMO01000042.1_35 |55981|56841|-|Loose|500|44.7|NDM-3|25.71|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MKIYPIETGNFKLDGGAMFGVVPKTIWQRTNPADENNLIDIAARSLLIEDGDRLVLIDTGMGNKQSDQFFGYYYRWGDFNIDSSLNKYGFHRDDITDVFLTHLHFDHVGGAIQWNKDRTGYEPAFKNAKFWTNEKHWKWATEPNPREKASFLKENLYPMKESGQLTFIDPTDNSFLKNSQLGFDIRFVDGHTEKQMLPQFTYQDKTIAYMADLIPTVGHIPLPYVIGYDTRPLVTMTEKEIFLNEAVENNYYLFFEHDAHNQLCTLKHTERGVRLDQVYTFNELFN
>UBA4585|DGJX01000028.1_2 # 2018 # 2878 # 1 # ID=140_2;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=11bp;gc_cont=0.488|DGJX01000028.1_2 |2018|2878|+|Loose|500|40.8|NDM-13|23.96|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTLHPIHTGNFKLDGGAMFGVVPKGLWERTNPADEKNLCTWAMRSLLIEDGDRLILIDTGIGNKQSEKFFSHYYLHGDHSLDASLALKGFSRDQITDVFLTHLHFDHVGGAVQWNKDRSGYEPAFKNAMYWTNERHWNWAIKPNARERASFLSENILPLQESGQLKFIKAPENQHRISTGLGFDAFVVNGHTDAQMCPILEYKGKKLVFMADLLPSTGHIPLPYVMGYDTRPLLTLDERKRIFTEAAENGYHLFLEHDAYNEVCTLEMTEKGPRLADNGRLDHYFR
>UBA4740|DHIS01000077.1_26 # 25421 # 26281 # 1 # ID=87_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.400|DHIS01000077.1_26 |25421|26281|+|Loose|500|39.7|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIETGNFKLDGGAMFGVVPKTIWNRTNPADENNLIDIAARCLLIEDGNQLILIDTGMGNKQSDKFFGYYSLWGNHSIDKSLAKHGFHRDDITDVFLTHLHFDHCGGSVQWNKDKTGYEVAFKNAKFWTNDSHWEWATKPNVREKASFLSENILPMQESGQLNFIKRPEGDFLPTSELGFGIFFADGHTEKQMLPHIQYQDKTIVFCADLLATAGHIPIPYVMGYDTRPLLTMDEKTKFMNAAAENNYYLFLEHDAHNEIITVEKTEKGVRLKERFSCDDILK
>UBA4788|DHGW01000070.1_65 # 77454 # 78293 # 1 # ID=59_65;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.538|DHGW01000070.1_65 |77454|78293|+|Loose|500|38.5|NDM-5|27.08|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|103.33|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MKISLFNISNFRVDGGAMFGVIPKALWSRQIMADENNTVDLSLTTLIVETGGRVILVDAGWGDKQDEKFFRHAYLHGGSGLTGGLAGCGYRPEDVTDVIITHLHADHCGGCFLNAPGGGQAPLFPDATYHISREQWEWANESNLREEDAFLPENIKPFGESGMLNLIEENSELCPGVTLKLFYGHTPGLMLPEIDFNGKKLFYAGDLFPTTAHIPLLWNMAYDLLPLVTIAEKQEILTEALHNDHLIIFQHDPVTECCALTETPKGIRAGKKGKLSDFL
>UBA4854|DHEI01000076.1_4 # 9438 # 10295 # -1 # ID=139_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.358|DHEI01000076.1_4 |9438|10295|-|Loose|500|40.0|NDM-5|23.81|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.56|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MKLYPIESGNFKLDGGAMFGVVPKTIWNKTNPADANNLIDIAARCLLIEDGNRLILIDTGMGDKQSEKFFGYYSLWGSHSLDKSLAKYGFNRDDVTDVFMTHLHFDHCGGSVQWNSDKTGYEPAFKNAKFWTNENHWEWATKPNAREKASFLSENILPMQESGQLNFVERPDSDFGFSKELGFDIYYVDGHTEKQMIPHIKYQDKTIVFCADLLATAGHIPLPYVMGYDTRPLLTMPEKSKFLNVAADNNHYLFLEHDAHNQIITVEHTEKGVRLKEVFTCEEIL
>UBA5015|DGYD01000248.1_4 # 3880 # 4665 # 1 # ID=94_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.562|DGYD01000248.1_4 |3880|4665|+|Loose|500|40.4|NDM-5|36.17|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|96.67|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MCLILIAYRYQPGYPLLIAANRDEFYNRPTEPLAQWQDTPHIIAGRDIQGGGTWLGITTTGRFAALTNYRDPSRLTPNAPSRGQLVSDYLRCTEPARQYLDRVVERANLYNGFNLLLGDSEGLFYYANYEGRPRELKPGLYGLSNHFLDTPWPKVERARTALRQILDQHAEPIPEDLLGLLRDQEPAPDHQLPDTGIPLEWERWLSPIFITAPGYGTRASTALCVQDSGRVRLVEITWPEHSQRQFQIEWPPLKLGIGHSP
>UBA5102|DHZO01000034.1_201 # 197036 # 197818 # 1 # ID=28_201;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.571|DHZO01000034.1_201 |197036|197818|+|Loose|500|193.0|NDM-10|39.27|3002360|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|96.30|gnl|BL_ORD_ID|61|hsp_num:0|70||
MRRLVGVILVAGLVACAPAQTEPANLEQIPTAQIAAQRGEISFEELAPGIWMHTSYKRVESWGDVVSHGMIVERGDHAVLIDSAWNDAQTTDILDWAEQDLGQPITLAVFTHAHSDKMGGVDAIRLRGGIRTLAHPLSNANAPWHGVSPAEEDLPLGDIGASTILDGLEIFYPGGGHTQDNIVVYDPENRLLFGGCLIRPGPSDNLGNTNDADLGYWAQAIANVDSRFPDATIVLPSHGDPAGRDLLNHTQLLATDIMED
>UBA5153|DHXP01000015.1_36 # 37010 # 37870 # 1 # ID=39_36;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.400|DHXP01000015.1_36 |37010|37870|+|Loose|500|39.7|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIETGNFKLDGGAMFGVVPKTIWNRTNPADENNLIDIAARCLLIEDGNQLILIDTGMGNKQSDKFFGYYSLWGNHSIDKSLAKHGFHRDDITDVFLTHLHFDHCGGSVQWNKDKTGYEVAFKNAKFWTNDSHWEWATKPNVREKASFLSENILPMQESGQLNFIKRPEGDFLPTSELGFGIFFADGHTEKQMLPHIQYQDKTIVFCADLLATAGHIPIPYVMGYDTRPLLTMDEKTKFMNAAAENNYYLFLEHDAHNEIITVEKTEKGVRLKERFSCDDILK
>UBA5180|DHWO01000172.1_12 # 6746 # 7561 # -1 # ID=118_12;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.676|DHWO01000172.1_12 |6746|7561|-|Loose|500|48.5|NDM-7|27.27|3002357|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|100.37|gnl|BL_ORD_ID|546|hsp_num:0|585||
MSEWLDVGADNYVLVTEGSLLNTGLIVGSERAMVVDTGCGPRQGREILDAVREKTSLPLVVVNTHAHYDHFFGNAVFASDGATEFWAHENCAREIDGHGDLQRRFVGTLEPEMSSGEGENVELVVPNAIVKDQPVLVDLGGVTATLFHLGRGHTDGDLLVGTPTTLFVGDLVEQGAHPSFEDSYPEEWADCLRHISALRHRYEFLIPGHGQPCSDQFVKTMANTMTTAVRQAQQSIRETPTDATKAIPVLPYGPEQSRWFIKRLQETRPLH
>UBA5594|DILK01000160.1_2 # 189 # 1040 # -1 # ID=267_2;partial=00;start_type=ATG;rbs_motif=AAGAA;rbs_spacer=5bp;gc_cont=0.433|DILK01000160.1_2 |189|1040|-|Loose|500|39.7|NDM-13|25.71|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|104.81|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYVLETGNFKLDGGAMFGVVPKTIWQRTNPADENNMCTWAMRCLLIEDGKRLMLVDTGIGNKQDEKFFSHYFLHGDATLDSSLQKLGFSRDQITDVFLTHLHFDHCGGAIEFDKSKDAFRPAFANATYWSNDRHWGWATQPNPREKASFLKENILPIKESGQLKMIERKEDLTAEVFPGIDVLFVDGHTDSMMIPHIRYKGKTIVYMADLLPSTGHIPLPYVMGYDTRPLLTISEKERFLKRAADEEFVLLLEHDSVNECCTLQHTEKGVRLKETFRFSEI
>UBA5788|DIDY01000002.1_600 # 670238 # 671152 # -1 # ID=10_600;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.583|DIDY01000002.1_600 |670238|671152|-|Loose|500|50.1|NDM-12|25.91|3002362|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|112.59|gnl|BL_ORD_ID|1790|hsp_num:0|1896||
MARTIEIADGIYQISTDNYRLNSGLIVGAERAMIVDTGAGPRQGAEILRAIRRITDLPLVAVNTHAHFDRFMGNAVFKADGVTDFWSHPRAGRAIEKYGDAQRPYVEVLEPEMAHAQGPNTELVPPTRFLPGDGTRPAFTRVELGERAITLIYLGLAHTDNDILVGVDDVLFTGDIVEQGSDPAFDDSFPELWVKTLQTLVGLDRYRIFVPGHGTPVERTFIERMAETMQDAIQKISESALTRVKGATTASMYQLPYSGGSTRILLDRLQKLQRFEEQGQPLAAVNFDATEPSGLTGPITLGNG
>UBA5789|DIDX01000004.1_777 # 890795 # 891631 # 1 # ID=8_777;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=8bp;gc_cont=0.437|DIDX01000004.1_777 |890795|891631|+|Loose|500|40.0|NDM-17|26.61|3004093|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|102.96|gnl|BL_ORD_ID|2275|hsp_num:0|2756||
MQLHTIDTGFFKLDGGAMFGVVPKSLWQRTNPADEKNLCTWATRLLLIEEGSRLILIDTGLGDKQDAKFFGHYDLHGDDTLDKSLARLGYNRQDITDVFLTHLHFDHCGGAIVRDGDKLIPSFANATYWSNEKHWNWATVDPNPREKASFLAENILPIQASGQLKFIGEGQALTENIDIRLANGHTEAMMLPQIRYKGKTILYMADLLPSVGHIPIPYVMSYDVRPLTTMEERKSYWEEIADQEYILFLEHDPVNECCTLQHTEKGIRLKDTFRLSDI
>UBA5871|DJFN01000192.1_15 # 12473 # 13333 # 1 # ID=199_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.491|DJFN01000192.1_15 |12473|13333|+|Loose|500|40.0|NDM-5|24.76|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MKIYPIETGTFKLDGGAMFGVVPKSLWQKTNPADENNLCTWSMRCLLIEDGNRLMLIDTGIGDKQSEKFFSHYYLADTKTLEQSLNKLGFGLDQITDVFLTHLHFDHCGGAVKWNSDRTKAEVVFPNATYWSTENHWEWATKPNPREKASFLSENILPMQESGQLQFVRREGNFTKNAFNNVDILFVDGHTESMMVPHIHYKGKTLVFMADLLPSTGHIPLPYVMGYDTRPLQTLVEKEAFLNTAADQEFVLFLEHDSVNECCTLQHTEKGVRLGETASFASLFGQ
>UBA5950|DJCM01000019.1_16 # 17061 # 17903 # 1 # ID=37_16;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=9bp;gc_cont=0.419|DJCM01000019.1_16 |17061|17903|+|Loose|500|40.0|NDM-3|26.04|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|103.70|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MNLFPINAGHFKLDGGAMFGVVPKSLWQRTNPADKDNLINVCARCLLIETGDRLVLVDTGMGNKQSNKFFSYYKPWGEDNLLDSITNAGFHPNDITDVLLTHLHFDHCGGCFTWNKDHSSFEPVFPNADYWSNESHWEWATNPNPREKASFLDDNLRPIEESGRLRFMQENKENPLNLELLFVDGHTEKQMLPVLDWKGEKIVFMGDLIPTIGHIPVPYVMGYDVRPLQTLVEKAAFLDLAAEKGYLLFMEHDPNSPLIKVHQTENGVRLQSSHQWNEFF
>UBA5955|DJCH01000040.1_4 # 2522 # 3364 # -1 # ID=41_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.421|DJCH01000040.1_4 |2522|3364|-|Loose|500|40.0|NDM-3|26.04|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|103.70|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MNLFPINAGHFKLDGGAMFGVVPKSLWQRTNPADKDNLINVCARCLLIETGDRLVLVDTGMGNKQSNKFFSYYKPWGEDNLLDSITNAGFHPNDITDVLLTHLHFDHCGGCFTWNKDHSSFEPVFPNADYWSNESHWEWATNPNPREKASFLDDNLRPIEESGRLRFMQENKENPLNLELLFVDGHTEKQMLPVLDWKGEKIVFMGDLIPTIGHIPVPYVMGYDVRPLQTLVEKAAFLDLAAEKGYLLFMEHDPNSPLIKVHQTENGVRLQSSHQWNEFF
>UBA6026|DIZO01000050.1_36 # 37123 # 37983 # 1 # ID=42_36;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.400|DIZO01000050.1_36 |37123|37983|+|Loose|500|39.7|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIETGNFKLDGGAMFGVVPKTIWNRTNPADENNLIDIAARCLLIEDGNQLILIDTGMGNKQSDKFFGYYSLWGNHSIDKSLAKHGFHRDDITDVFLTHLHFDHCGGSVQWNKDKTGYEVAFKNAKFWTNDSHWEWATKPNVREKASFLSENILPMQESGQLNFIKRPEGDFLPTSELGFGIFFADGHTEKQMLPHIQYQDKTIVFCADLLATAGHIPIPYVMGYDTRPLLTMDEKTKFMNAAAENNYYLFLEHDAHNEIITVEKTEKGVRLKERFSCDDILK
>UBA6031|DIZJ01000086.1_55 # 54972 # 55832 # 1 # ID=100_55;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.400|DIZJ01000086.1_55 |54972|55832|+|Loose|500|39.7|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIETGNFKLDGGAMFGVVPKTIWNRTNPADENNLIDIAARCLLIEDGNQLILIDTGMGNKQSDKFFGYYSLWGNHSIDKSLAKHGFHRDDITDVFLTHLHFDHCGGSVQWNKDKTGYEVAFKNAKFWTNDSHWEWATKPNVREKASFLSENILPMQESGQLNFIKRPEGDFLPTSELGFGIFFADGHTEKQMLPHIQYQDKTIVFCADLLATAGHIPIPYVMGYDTRPLLTMDEKTKFMNAAAENNYYLFLEHDAHNEIITVEKTEKGVRLKERFSCDDILK
>UBA6046|DIYU01000169.1_5 # 5442 # 6302 # -1 # ID=72_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.401|DIYU01000169.1_5 |5442|6302|-|Loose|500|39.7|NDM-13|23.81|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIETGNFKLDGGAMFGVVPKTIWNRTNPADENNLIDIAARCLLIEDGNQLILIDTGMGNKQSDKFFGYYSLWGNHSIDKSLAKHGFHRDDITDVFLTHLHFDHCGGSVQWNKDKTGYEVAFKNAKFWTNDSHWEWATKPNVREKASFLSENILPMQESGQLNFIKRPEGDFLPTSELGFGIFFADGHTEKQMLPHIQYQDKTIVFCADLLATAGHIPIPYVMGYDTRPLLTMDEKTKFMNAAAENNYYLFLEHDAHNEIITVEKTEKGVRLKERFSCDDILK
>UBA6052|DIYO01000001.1_479 # 552077 # 552925 # -1 # ID=1_479;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.397|DIYO01000001.1_479 |552077|552925|-|Loose|500|38.1|NDM-5|26.04|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|104.44|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MHLHVINTGNFKLDGGAMFGVVPKSLWQRTNPADDNNMCTWAMRSLLIEDGDRLILIDNGIGDKQDAKFFSYYYLHGEDSLDSSLKKAGFSPDDVTDMFMTHLHFDHCGGGVDYVGDNQDKLALHFKNASYWSNADHWEWATKPNPREKASFLKENILPIEESGHLKHVDLKSSSPFSQFDIITADGHTDKQMLPKIKYKDKTIVFMADLLPSAGHIPLPYVMGYDTRPLKTMSEKAAFLEEAAENEYILFLEHDPINECCTVKKTDRGVRLDKTFSLNEIL
>UBA6131|DIVN01000213.1_1 # 387 # 1250 # 1 # ID=23_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.611|DIVN01000213.1_1 |387|1250|+|Loose|500|46.6|NDM-7|22.71|3002357|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|546|hsp_num:0|585||
MRRDRVAEDVYTFTSDRYAQVTAGAILTSEGTIVIDTLPFPEETQELLDFVEKRGQGPVRYVILTHHHSDHTNGTFLFPQAEVLAHPNCRLALQKWGAESLAEARKQTRGLREVEIRLPTAVSQDDFYLHLGARSLYITALPGHTDNCIGVLVEGDKILFAGDAMLPVPHFLWGDIRDSARSLRAIRSLKPESVVQGHGQLLLRGELAEEIEASLEYLRCLEERVGELVQQNAPESALYNIDIESCGKSRVPLDGLVQHLHNENLYALYMQMKGERKPRRATSAPVM
>UBA6274|DJUU01000091.1_2 # 1038 # 1958 # 1 # ID=89_2;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.377|DJUU01000091.1_2 |1038|1958|+|Loose|500|40.0|NDM-3|26.04|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|113.33|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MLLILQYVLLFCKVTLKFMNLYPIEAGNFKLDGGAMFGVVPKSIWQRTNPADEHNMIDLATRCLLIEDGNRLILVDTGMGNKQSEKFFSYYYLWGTHSIDQSFSKLGFHRNDVTDVFMTHLHFDHCGGSVQWNADRTGYEPAFKNATFWSNANHWDWATKPNAREKASFLKENILPLEESGQLKFISVPNTDLKESSELGFGVFFANGHTEKQMIPMIDYKGKTICFMADLLPTVGHLPLPYVMGYDTRPLLTLPEKEKFLNLAADNNYYLFLEHDAHNQIITVQHTEKGVRLKDTFTCNDIFKSN
>UBA6320|DJTA01000010.1_6 # 9864 # 10700 # -1 # ID=30_6;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.370|DJTA01000010.1_6 |9864|10700|-|Loose|500|38.9|NDM-10|23.96|3002360|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|102.96|gnl|BL_ORD_ID|61|hsp_num:0|70||
MQLYTIETQNFKLDGGAMFGVVPKSIWHKTNPADSNNMCTWTNRLLLIEDGAKLILVDTGLGDKQSEKFFGHYYIHGDNSIDKSLAKHGFNREDITDVILTHLHFDHCGGAIARQGDKLRPSFTNANYWSNAAHWDWAIHPNPREKASFLEENIIPIQESGQLKFIEKESSPFGPNIQIRYAHGHTESMMLPQIQYKNKTILYMADLLPSVGHIPLPYVMSYDIRPLTTMEERNNYWQEIVDREYILFLEHDAVNACCTLQHTEKGIRLKESFQLSDI
>UBA6497|DJMF01000128.1_7 # 8666 # 9529 # -1 # ID=66_7;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=11bp;gc_cont=0.377|DJMF01000128.1_7 |8666|9529|-|Loose|500|39.3|NDM-5|25.0|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MQLYPIEAGNFKLDGGAMFGVVPKSIWQKTNPADSNNMIDIGARSLLIEDGNRLILIDTGLGDKQSEKFFSYYYQWGDDSLDKSLQKNGFHRDDITDVFTTHLHFDHCGGCVQWNKDRTGYETVFKNAKYWSNKDHWQWATTPNAREKASFLKENILPIEESGQLHFVDRNNKEHFTNIPELGFGVLFVDGHTDKQMIPHLEYKGKKLVFMADLLPTAGHIPLPYVMGYDTRPLLTLPEKKSFLDKAADEEIYLFMQHDAHNEVITVKHTEKGVRHDQTYTFNELFN
>UBA6511|DJLR01000013.1_42 # 67133 # 67993 # -1 # ID=57_42;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.364|DJLR01000013.1_42 |67133|67993|-|Loose|500|44.7|NDM-3|25.71|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MKIYPIETGNFKLDGGAMFGVVPKTIWQRTNPADENNLIDIAARSLLIEDGDRLVLIDTGMGNKQSDQFFGYYYRWGDFNIDSSLNKYGFHRDDITDVFLTHLHFDHVGGAIQWNKDRTGYEPAFKNAKFWTNEKHWKWATEPNPREKASFLKENLYPMKESGQLTFIDPTDNSFLKNSQLGFDIRFVDGHTEKQMLPQFTYQDKTIAYMADLIPTVGHIPLPYVIGYDTRPLVTMTEKEIFLNEAVENNYYLFFEHDAHNQLCTLKHTERGVRLDQVYTFNELFN
>UBA6515|DJLN01000016.1_3 # 2751 # 3593 # 1 # ID=37_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.431|DJLN01000016.1_3 |2751|3593|+|Loose|500|43.9|NDM-7|24.56|3002357|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|103.70|gnl|BL_ORD_ID|546|hsp_num:0|585||
MNLFPIVAGRFKLDGGAMFGVVPKSIWQRTNPADEDNLIDLCARCLLIESGDRLILVDTGMGDKQSERFFNYYKPWGNDNLVDSVIGAGFHPNDVTDVLLTHLHFDHCGGCFTWNADRTSFVPVFPNADYWSNESHWQWATQPNPREKASFLKDNLNPIQESGRLRFIDKGRDNPLGLDLLFVDGHTEKQMLPMVDWKGEKLVFMGDLIPTVGHIPLPYIMGYDVRPLETLVEKSAFLDLAAENNYLLFLEHDPNTPLVRVHQTEKGVRLQSSHQWNEFI
>UBA6600|DJIG01000080.1_9 # 10962 # 11825 # 1 # ID=99_9;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=11bp;gc_cont=0.382|DJIG01000080.1_9 |10962|11825|+|Loose|500|39.3|NDM-5|25.0|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.30|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MQLYPIEAGNFKLDGGAMFGVVPKSIWQKTNPADSNNMIDIGARSLLIEDGNRLILIDTGLGDKQSEKFFSYYYQWGDDSLDKSLQKNGFHRDDITDVFTTHLHFDHCGGCVQWNKDRTGYETVFKNAKYWSNKDHWQWATTPNAREKASFLKENILPIEESGQLHFVDRNNKEHFTNIPELGFGVLFVDGHTDKQMIPHLEYKGKKLVFMADLLPTAGHIPLPYVMGYDTRPLLTLPEKKSFLDKAADEEIYLFMQHDAHNEVITVKHTEKGVRHDQTYTFNELFN
>UBA6602|DJIE01000182.1_28 # 26308 # 27243 # -1 # ID=65_28;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.674|DJIE01000182.1_28 |26308|27243|-|Loose|500|44.3|NDM-7|33.0|3002357|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|115.19|gnl|BL_ORD_ID|546|hsp_num:0|585||
MSARCIVLLCLWLLCAITPAGANDYYDLVPQRIAPDTYVFLGALEAFDFDNHGAVANSGFIVTEQGVVVIDTGPSRLYGEAMRAAIAHVTDRPVVRVYITHAHADHFLGNNAFADVPIAALPATARTIRSAGEAMARHLYDRVGAAMRGTSAVVPDEIIMPDMEPVVDYGDHRLELIATAGHSPADLMILDRRTGVLFAGDVVFHDRAPATPHGDIAGWQQALAGAARTGFRIVVPGHGPVASDDTPLEQTGAYLRWLVERLQAGAARGDSAAELMFEALPPRWAALAVQPAEYRRSVTYLYPALEKATLE
>UBA6619|DJHN01000054.1_8 # 10960 # 11820 # 1 # ID=11_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.340|DJHN01000054.1_8 |10960|11820|+|Loose|500|38.5|NDM-13|25.0|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPINAGNFKLDGGAMFGVVPKSLWQRTNPADNNNMIDIAARCLLIEDGDRLILIDTGMGNKQSDKFYGYYYLWGDDTIDKSLAEYGFHRDDITDVFMTHLHFDHCGGSIQWNKDRTVLEPAFKNANFWSNADHWKWATEPNRREKASFLKENILPMEECGQLKFTALPEDKILKNSELGFDIFFADGHTDKQMIPMINYKGKTICFMADLLPTAGHLPLPFVMGYDTRPLLTLDEKELFLNMAADENYYLFLEHDAHNEIITVKHTEKGVRLNENYTCKEIFN
>UBA6645|DKLH01000087.1_63 # 69220 # 70062 # 1 # ID=56_63;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.394|DKLH01000087.1_63 |69220|70062|+|Loose|500|42.4|NDM-5|29.17|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|103.70|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MKLYTIDTGFFKLDGGAMFGVVPKSIWQKTNPADSNNLCTWATRLLLIEDGKRLTLVDTALGDKQDAKFFGHYFLHGDDTLDKSLAKYGFHREDITDVILTHLHFDHCGGAIVREGEKLVPAFKNARFWSNEKHWNWATIDPNPREKASFLKENILPIQESGQLNFLSEEQPQYDNSITMRYAYGHTEAMMLPQLEYKGKTLLYMADLLPSVGHIPLAYVMSYDVRPLVTMDERKSYWQEIVDNEYILILEHDAQHECCTLQHTEKGIRLKDTFRLSDIV
>UBA6711|DKIT01000073.1_7 # 5375 # 6211 # 1 # ID=176_7;partial=00;start_type=ATG;rbs_motif=AAAAA;rbs_spacer=6bp;gc_cont=0.411|DKIT01000073.1_7 |5375|6211|+|Loose|500|38.9|NDM-17|24.76|3004093|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|102.96|gnl|BL_ORD_ID|2275|hsp_num:0|2756||
MKLHAIETGFFKLDGGAMFGVVPKSIWNKTNPADANNMCTWGNRLLLIEDGSRLMLVDTGLGDKQNEKFFSYYYLHGDATLDKSLKRIGFDRNDITDVILTHLHFDHCGGAIAREGNKLVPAFKNADFWSNRDHWSWATDPNPREKASFLKENILPIQESGRLKWVEDQSNPFGKDIVIRYAHGHTEAMMLPQIQYKGKTVLYMADLLPSVGHIPIPYVMGYDIRPLVTMEERNSYWNEIVEKEYILFFEHDPINECCTLQHTEKGIRVKDIFRLDEI
>UBA6721|DKIJ01000031.1_80 # 81022 # 81882 # -1 # ID=23_80;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.350|DKIJ01000031.1_80 |81022|81882|-|Loose|500|38.5|NDM-13|22.86|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLYPIETGNFKLDGGAMFGVVPKTIWNKTNPADANNLIDIAARCLLIEDGNRLILIDSGMGNKQSEKFFGYYSLWGTHSMDASLAKYGFHRDDITDVFLTHLHFDHCGGCIQWNKDRTGYEPAFQNARFWSNENHWKWATEPNSREKASFLSENILPMQESGQLHFIKRYEGDFVDKSELGFDIFFVDGHTEKQMIPLIQYQGKTIVFCADLLPTAGHIPIPYVMGYDTRPLLTMNEKTKFMNIAASNNYYLFLEHDAHNEIITVQHTEKGVRLKEILSNEDFLI
>UBA6787|DKFV01000012.1_4 # 3469 # 4338 # 1 # ID=98_4;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.386|DKFV01000012.1_4 |3469|4338|+|Loose|500|42.0|NDM-13|24.76|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|107.04|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTLYTIETGNFKLDGGAMFGVVPKTIWQKTNPADEKNLIDIAARSLLIEDGDKLILIDTGLGNKQSDKFFGYYYRWGNDSIDSSLAKHGFHRDDITDVFMTHLHFDHCGGSIQWNKDRSGFEPAFKNAKFWTNKDHWKWAIEPNAREKASFLKENLLPMQESGQLNFIDRGTDAFLKNSVLGFDVLFVDGHTDKQMLPHIRYKGKTLVFVADLIPTVGHIPLPYVIGYDTRPLLTLKEKDVFLKEALKNEYFLFFEHDAHNEICTLRETEKGARLDNTFTFNELFNTTA
>UBA6904|DKBI01000214.1_16 # 11478 # 11768 # 1 # ID=207_16;partial=01;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.663|DKBI01000214.1_16 |11478|11768|+|Loose|500|37.4|NDM-13|25.42|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|35.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTTTYPVGRWQVGAVRITRVVEIEGPSPGTFLFAEATPERLLQHAWLRPHFVTDDGRSIGSIHAFVIESEGRCIVVDTCIGNDKPREIANWNMRQGR
>UBA6931|DKAH01000014.1_163 # 195289 # 196134 # 1 # ID=9_163;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.472|DKAH01000014.1_163 |195289|196134|+|Loose|500|38.5|NDM-5|25.66|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|104.07|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MRIGNFDVTTLITSRFGLDGGSMFGVIPKSIWDKNAAVDSDNRISLVTRSLLIRGDGRIILVDTGSGDKWDGKMKNILAIDPTETNITDTLAQHAVLPDEVTDVICTHLHFDHSGGNTRIEGDQTIPTFPNATYHLQRDNWEWASSPTEKDRGSYRSENWEAITENGMFNLLEAKEPIFDNIKLHLTHGHTPGQMHPILTEGEKTLFFAGDLFPTRLHFRLPCIMAFDNEPLKTLMEKKEVLRRASDEGWIIILAHDPDCEAVKVYAQGDRFQIEKVFNLD
>UBA6968|DJYW01000084.1_10 # 10454 # 11320 # 1 # ID=181_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.522|DJYW01000084.1_10 |10454|11320|+|Loose|500|42.7|NDM-3|28.57|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.67|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MNQWQIGSVTITRVVEMQVAGGTRFILPDATRELCRPIEWMHPHFMDDDGNLIMSIHGLVVDTGTRRILVDTCVGNDKERSVPNWTNLQTTFLQDLAAAGYPRESIDTVLCTHLHVDHVGWNTMLVDGKWEPTFTNARYLIAEEEWTHWDSVDGDDFGPVIEDSVRPVIAAGLVDLVTTNHRVCDEVWLEPTPGHTPGHVSVHVQSEGQSALITGDCIHHPVQMTKTDWCSSADFDQKQGQDTRELLLRRYVDKDTLVIGTHFATPTAGYVKALADGGYWLQTEAFNP
>UBA7182|DKVI01000062.1_19 # 22518 # 23372 # -1 # ID=94_19;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.524|DKVI01000062.1_19 |22518|23372|-|Loose|500|45.1|NDM-8|32.56|3002358|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.19|gnl|BL_ORD_ID|576|hsp_num:0|616||
MDSKKRRLACLALILALLAFRGLVRGAWHAQENGQLTITALPVGKADALIVQQGGRTVVIDTGEEDDGAYLVKELKSRGAAKVDLLLITHFDKDHVGGAACLVEHMEVSSVMMPDYEGSRPEYRAFLESLKGHPDVRRVAAPEQFFAENMTFMIYPAENPGEIMDTDEEYDNGMSLVASLTYGAEKFLFAGDVEGVRIDQMLSEDIDWRHDWLKLPHHGKYEDALTDFLDAVDPDMTVICCSEKNPAEKKTLKLLEEKQTEVWDTSRKTVVTRSDGERITVSME
>UBA7218|DKTY01000106.1_18 # 23418 # 24272 # -1 # ID=7_18;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.524|DKTY01000106.1_18 |23418|24272|-|Loose|500|45.1|NDM-8|32.56|3002358|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.19|gnl|BL_ORD_ID|576|hsp_num:0|616||
MDSKKRRLACLALILALLAFRGLVRGAWHAQENGQLTITALPVGKADALIVQQGGRTVVIDTGEEDDGAYLVKELKSRGAAKVDLLLITHFDKDHVGGAACLVEHMEVSSVMMPDYEGSRPEYRAFLESLKGHPDVRRVAAPEQFFAENMTFMIYPAENPGEIMDTDEEYDNGMSLVASLTYGAEKFLFAGDVEGVRIDQMLSEDIDWRHDWLKLPHHGKYEDALTDFLDAVDPDMTVICCSEKNPAEKKTLKLLEEKQTEVWDTSRKTVVTRSDGERITVSME
>UBA7249|DKST01000015.1_385 # 424460 # 425296 # -1 # ID=11_385;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=4bp;gc_cont=0.405|DKST01000015.1_385 |424460|425296|-|Loose|500|38.9|NDM-5|26.67|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|102.96|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MKLHAIETGFFKLDGGAMFGVVPKSIWNKTNPADANNMCTWGNRLLLVEEGKRLMLVDTGLGDKQTEKFFSHYYLHGDATLDKSLKSIGFDRNDITDVVLTHLHFDHCGGAIIREGEKLCPAFKNANFWSNNDHWAWATAPNAREKASFLKENILPIQESGQLKFVEDVEEPFGKEIDIRYAHGHTEAMMLPQIQYKGKTILYMADLLPSVGHIPIPYVMGYDVRPLITMDERNTYWNEIVDNEYILFLEHDPMNECCTLQHTEKGIRVKDIFKLSDI
>UBA724|DBLM01000015.1_16 # 17058 # 17900 # 1 # ID=37_16;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.431|DBLM01000015.1_16 |17058|17900|+|Loose|500|43.9|NDM-7|24.56|3002357|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|103.70|gnl|BL_ORD_ID|546|hsp_num:0|585||
MNLFPIVAGRFKLDGGAMFGVVPKSIWQRTNPADEDNLIDLCARCLLIESGDRLILVDTGMGDKQSERFFNYYKPWGNDNLVDSVIGAGFHPNDVTDVLLTHLHFDHCGGCFTWNADRTSFVPVFPNADYWSNESHWQWATQPNPREKASFLKDNLNPIQESGRLRFIDKGRDNPLGLDLLFVDGHTEKQMLPMVDWKGEKLVFMGDLIPTVGHIPLPYIMGYDVRPLETLVEKSAFLDLAAENNYLLFLEHDPNTPLVRVHQTEKGVRLQSSHQWNEFI
>UBA7358|DKOQ01000030.1_5 # 2984 # 3844 # 1 # ID=100_5;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=11bp;gc_cont=0.488|DKOQ01000030.1_5 |2984|3844|+|Loose|500|40.8|NDM-13|23.96|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTLHPIHTGNFKLDGGAMFGVVPKGLWERTNPADEKNLCTWAMRSLLIEDGDRLILIDTGIGNKQSEKFFSHYYLHGDHSLDASLALKGFSRDQITDVFLTHLHFDHVGGAVQWNKDRSGYEPAFKNAMYWTNERHWNWAIKPNARERASFLSENILPLQESGQLKFIKAPENQHRISTGLGFDAFVVNGHTDAQMCPILEYKGKKLVFMADLLPSTGHIPLPYVMGYDTRPLLTLDERKRIFTEAAENGYHLFLEHDAYNEVCTLEMTEKGPRLADNGRLDHYFR
>UBA7428|DLQQ01000035.1_10 # 8689 # 9546 # 1 # ID=22_10;partial=00;start_type=ATG;rbs_motif=AATAA;rbs_spacer=5bp;gc_cont=0.408|DLQQ01000035.1_10 |8689|9546|+|Loose|500|38.5|NDM-13|23.48|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.56|gnl|BL_ORD_ID|430|hsp_num:0|464||
MKLHRIETGNFMLDGGAMFGVVPKALWERTNPADEKNRIKMAARSLLIEDGDRLILIDTGMGNKQSDKFYGHYAIWGDHTLDSSLQKAGFHRDDITDVFFTHLHFDHCGGAIEFNSNGILVPAFKNARFWSHQNHWEWAKKPNPREKASFLPENILPIHESGQLELLIGTEKQLKKTALGFDILLMDGHTEKQMLPMIQYQGKTIVFAADLIPTVGHLPIPYVMGYDTRPLLTLEEKASFLDRAVANDFLLFLEHDAENELISLEQTAKGVRCKESFLFDNYFKS
>UBA7429|DLQP01000135.1_2 # 1547 # 2407 # 1 # ID=17_2;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=11bp;gc_cont=0.488|DLQP01000135.1_2 |1547|2407|+|Loose|500|40.8|NDM-13|23.96|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTLHPIHTGNFKLDGGAMFGVVPKGLWERTNPADEKNLCTWAMRSLLIEDGDRLILIDTGIGNKQSEKFFSHYYLHGDHSLDASLALKGFSRDQITDVFLTHLHFDHVGGAVQWNKDRSGYEPAFKNAMYWTNERHWNWAIKPNARERASFLSENILPLQESGQLKFIKAPENQHRISTGLGFDAFVVNGHTDAQMCPILEYKGKKLVFMADLLPSTGHIPLPYVMGYDTRPLLTLDERKRIFTEAAENGYHLFLEHDAYNEVCTLEMTEKGPRLADNGRLDHYFR
>UBA7433|DLQL01000002.1_22 # 24640 # 25506 # 1 # ID=26_22;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.443|DLQL01000002.1_22 |24640|25506|+|Loose|500|38.5|NDM-10|25.71|3002360|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|106.67|gnl|BL_ORD_ID|61|hsp_num:0|70||
MRVYPIETGQLKLDGGAMFGVVPKTIWQRSNPADANNRINLTMRCLLIEDGKRLLLIDTGMGNKQSATFFEHYYLSGAHTLDCSLADLGFHRDDITDVFLTHLHFDHCGGSIQWNASKTGYEPAFKNAKYWSNQAHWKWATQPNPREKASFLTENILPIEESGQLHFVELSKERYSFVPALELEVLCVDGHTEKQMLPKIKYKGKTLVFVADLIPTVGHLPLPYVMSYDTRPLLTMSEKALFLNEAADRGYYLFLEHDAQHELCTVHHTKKGVRLQNSHTFNEVFNSF
>UBA7665|DLHP01000041.1_32 # 39035 # 39841 # -1 # ID=22_32;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=15bp;gc_cont=0.482|DLHP01000041.1_32 |39035|39841|-|Loose|500|37.7|NDM-13|24.73|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|99.26|gnl|BL_ORD_ID|430|hsp_num:0|464||
MFGVVPKTIWNKTNPADANNLIDIAARCLLIEDGNRLIIVDTGMGNKQSEKFFGYYSLWGDDTIDKSLAKYDFSRDDITDVFMTHLHFDHCGGSVQWNNDKTGYEPAFKNAKFWSNDNHWLWATKPNPREKASFLTENILPMQESGQLEFIKRPDGDTLEKSELGFGIFFADGHTEKMMIPKIQYQDKTICFMADLLPTAGHIPLPYVMGYDTRPLLTLPEKAKFLTEAADNNYYLMLEHDAHNEIITVENTDKGVRLKEVFSCSDLF
>UBA7680|DLHA01000050.1_5 # 3946 # 4803 # 1 # ID=7_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.353|DLHA01000050.1_5 |3946|4803|+|Loose|500|38.5|NDM-5|24.76|3000467|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.56|gnl|BL_ORD_ID|1038|hsp_num:0|1106||
MKLYPIESGNFKLDGGAMFGVVPKTIWNKTNPADENNLIDIAARCLLIEDGKRLILIDTGMGDKQSEKFFGYYSLWGSHSIDKSLSKYGFHRDDVTDVFMTHLHFDHCGGSVQWNSDKTFYEPAFKNAKFWTNENHWNWATKPNPREKASFLTENIIPMQESGQLNFVERPESDFGFSNELGFGIFYADGHTEKQMIPHIQYQDKTIVFCADLLATAGHLPLPYVMGYDTRPLLTMPEKAKFLNAAADNNYYLFLEHDAHNQIITVEHTEKGVRLKEVFTCEDIF
>UBA849|DBGR01000054.1_22 # 25015 # 25875 # -1 # ID=54_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.364|DBGR01000054.1_22 |25015|25875|-|Loose|500|44.7|NDM-3|25.71|3002354|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|105.93|gnl|BL_ORD_ID|1424|hsp_num:0|1515||
MKIYPIETGNFKLDGGAMFGVVPKTIWQRTNPADENNLIDIAARSLLIEDGDRLVLIDTGMGNKQSDQFFGYYYRWGDFNIDSSLNKYGFHRDDITDVFLTHLHFDHVGGAIQWNKDRTGYEPAFKNAKFWTNEKHWKWATEPNPREKASFLKENLYPMKESGQLTFIDPTDNSFLKNSQLGFDIRFVDGHTEKQMLPQFTYQDKTIAYMADLIPTVGHIPLPYVIGYDTRPLVTMTEKEIFLNEAVENNYYLFFEHDAHNQLCTLKHTERGVRLDQVYTFNELFN
>UBA893|DBEZ01000116.1_4 # 4546 # 5415 # 1 # ID=87_4;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=11bp;gc_cont=0.386|DBEZ01000116.1_4 |4546|5415|+|Loose|500|42.0|NDM-13|24.76|3003182|protein homolog model|n/a|n/a|carbapenem; cephalosporin; cephamycin; penam|antibiotic inactivation|NDM beta-lactamase|107.04|gnl|BL_ORD_ID|430|hsp_num:0|464||
MTLYTIETGNFKLDGGAMFGVVPKTIWQKTNPADEKNLIDIAARSLLIEDGDKLILIDTGLGNKQSDKFFGYYYRWGNDSIDSSLAKHGFHRDDITDVFMTHLHFDHCGGSIQWNKDRSGFEPAFKNAKFWTNKDHWKWAIEPNAREKASFLKENLLPMQESGQLNFIDRGTDAFLKNSVLGFDVLFVDGHTDKQMLPHIRYKGKTLVFVADLIPTVGHIPLPYVIGYDTRPLLTLKEKDVFLKEALKNEYFLFFEHDAHNEICTLRETEKGARLDNTFTFNELFNTTA
